AstraZeneca PLC (LON:0A4J)

London flag London · Delayed Price · Currency is GBP · Price in USD
67.00
+0.17 (0.25%)
At close: Apr 22, 2025
-2.10%
Market Cap 165.92B
Revenue (ttm) 42.56B
Net Income (ttm) 6.02B
Shares Out n/a
EPS (ttm) 3.85
PE Ratio 27.58
Forward PE 15.64
Dividend 1.20 (1.79%)
Ex-Dividend Date Feb 21, 2025
Volume 19
Average Volume 8,718
Open 67.00
Previous Close 66.83
Day's Range 67.00 - 67.00
52-Week Range 62.79 - 87.62
Beta 0.18
RSI 44.08
Earnings Date Jul 29, 2025

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Crestor, Seloken, Lokelma, Roxadustat, Andexxa, Wainua, Symbicort, Fasenra, Pulmicort, Breztri/Trixeo, Saphnelo, Tezspire, Airsupra, Ultomiris, Soliris, Strensiq, Koselugo, Kanuma, Atacand, Plendil, Modip, Splendil, Munobal, Flodil, Komboglyze, Qtern, B... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 94,300
Stock Exchange London Stock Exchange
Ticker Symbol 0A4J
Full Company Profile

Financial Performance

In 2024, AstraZeneca's revenue was $54.07 billion, an increase of 18.03% compared to the previous year's $45.81 billion. Earnings were $7.04 billion, an increase of 18.14%.

Financial numbers in USD Financial Statements

News

There is no news available yet.